DALLAS, Oct. 15, 2026 /PRNewswire/ -- SenderraRx announced that it has earned reaccreditation in Specialty Pharmacy from the Accreditation Commission for Health Care (ACHC), including a Distinction in Oncology. Reaccreditation reflects an independent evaluation against nationally recognized standards for specialty pharmacy quality, safety, and patient care. The Oncology Distinction recognizes Senderra's oncology-focused clinical oversight, medication management, patient education, adherence support, and care coordination for patients navigating complex cancer therapies.

"This recognition reflects the expertise and commitment our team brings to patients navigating complex cancer therapies," said Will Howard, CEO of Senderra Specialty Pharmacy. "Our role extends beyond dispensing medication. We help patients understand their treatment, coordinate with their care teams, and overcome challenges that could interrupt therapy. Earning the Oncology Distinction affirms the disciplined, patient-centered approach our team applies every day."

The ACHC reaccreditation adds to Senderra's existing URAC accreditations in Specialty Pharmacy and Mail Service Pharmacy under URAC's version 6.0 standards. Collectively, these accreditations demonstrate that Senderra's pharmacy operations, medication distribution, patient management, and service practices have been independently evaluated against current industry standards.

Accreditation is recognized by health plans, pharmacy benefit managers, and pharmaceutical manufacturers as an indicator of quality and may be considered in specialty pharmacy network and limited-distribution program participation. Maintaining accreditation from both ACHC and URAC supports Senderra's work with payer and manufacturer partners and its delivery of coordinated clinical and patient support services.

About SenderraRx

SenderraRx is the largest, national, independent specialty pharmacy that provides medications, clinical management, medication access support, and patient services for people with complex and chronic conditions. Senderra utilizes technology solutions to enhance the patient and provider experience while promoting greater access to care. We work together with patients, prescribers, pharmaceutical manufacturers, and payer partners to coordinate therapy, assure access and support continuity of care. For more information, visit www.senderrarx.com.

About ACHC

The Accreditation Commission for Health Care (ACHC) is a nonprofit accreditation organization founded in 1986 that offers nationally recognized accreditation programs for pharmacies and other healthcare providers. ACHC's Specialty Pharmacy Accreditation evaluates an organization's policies, processes, and patient outcomes against industry standards, and its distinctions recognize advanced expertise in specific areas of care, such as oncology. For more information, visit www.achc.org.

About URAC

Founded in 1990 as a non-profit organization, URAC is the independent leader in promoting health care quality and patient safety through renowned accreditation programs. URAC develops its evidence-based standards in collaboration with a wide array of stakeholders and industry experts. The company's portfolio of accreditation and certification programs spans the health care industry, addressing health equity, workplace mental health, health care management and operations, pharmacies, telehealth, health plans, medical practices and more. URAC accreditation is a symbol of excellence for organizations to showcase their validated commitment to quality and accountability. For more information, visit www.urac.org.

View original content to download multimedia:https://www.prnewswire.com/news-releases/senderrarx-earns-achc-reaccreditation-in-specialty-pharmacy-and-oncology-distinction-302910493.html

SOURCE Senderra Specialty Pharmacy